MSB 10.4% $1.49 mesoblast limited

If the FDA meeting goes well, they could have the green light...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,491 Posts.
    lightbulb Created with Sketch. 8962
    If the FDA meeting goes well, they could have the green light for the adult trial SR- aGVHD trial… on top of that the CLBP pivotal trial is recruiting. Both could finish recruiting by end of this year. Results early to mid next year. CLBP has a strong chance of an early stop and SR aGVHD has a short end point.

    along side that, again if FDA meetings go to plan… two AA BLA’s could be submitted end of this year or early next.

    Even before read outs, or outcomes from BLA’s are known… that is a lot of fuel to drive the share price higher, especially with all the recent funding behind us… it’s looking like a good run to mid 2025

    goodluck all
    Last edited by stockrock: 20/03/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.